Leuprolide and blood bilirubin increased 
Leuprolide and blood bilirubin increased Patient Reports February 12, 2012
Leuprolide Side Effects Report #5794223-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 17, 2008. Male patient, 77 years of age, was diagnosed with prostate cancer stage iv, hypertension, hyperlipidaemia, atrial fibrillation
, hyperuricaemia, stomach discomfort, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebellar haemorrhage, hepatic function abnormal, red blood cell count decreased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, NISOLDIPINE, PRAVASTATIN, WARFARIN, ALLOPURINOL, P MAGEN, HARNAL D. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5814243-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 17, 2008. Male patient, 77 years of age, was diagnosed with prostate cancer stage iv, hypertension, hyperlipidaemia, atrial fibrillation
, hyperuricaemia, stomach discomfort, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebellar haemorrhage, hepatic function abnormal, red blood cell count decreased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, NISOLDIPINE, PRAVASTATIN, WARFARIN POTASSIUM, ALLOPURINOL, P MAGEN, HARNAL D. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5816898-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 17, 2008. Male patient, 77 years of age, was diagnosed with prostate cancer stage iv, hypertension, hyperlipidaemia, atrial fibrillation
, hyperuricaemia, stomach discomfort, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebellar haemorrhage, hepatic function abnormal, red blood cell count decreased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, NISOLDIPINE, PRAVASTATIN, WARFARIN POTASSIUM, ALLOPURINOL, P MAGEN, HARNAL D. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4845409-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 17, 2005. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, gamma-glutamyltransferase increased, jaundice
, liver disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4846028-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 28, 2005. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alcoholic liver disease, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, gamma-glutamyltransferase increased, jaundice
, liver disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4875734-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, condition aggravated, dyspepsia, gamma-glutamyltransferase increased, jaundice
. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4895456-4
Leuprolide side effect was reported by a Health Professional from JAPAN on Jan 23, 2006. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, gamma-glutamyltransferase increased, jaundice
, liver disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D), SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5277979-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 13, 2007. Male patient, 86 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, brain stem infarction, cerebral circulatory failure, cerebral infarction, eye disorder, eyelid function disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with HARNAL D, BLADDERON, TRYPTANOL. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4951393-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 16, 2006. Male patient, 85 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, jaundice . Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CASODEX, URSO, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5128061-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Oct 06, 2006. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, hepatomegaly, jaundice . Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE, BEZATOL, DORAL, EVAMYL. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5151883-1
Leuprolide side effect was reported by a Physician from JAPAN on Nov 07, 2006. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, hepatomegaly, jaundice , ocular icterus. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE, BEZATOL, DORAL, EVAMYL. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4711136-X
Leuprolide side effect was reported by a Physician from JAPAN on July 06, 2005. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bedridden, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, central venous pressure decreased, dehydration, dysphagia. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with HALCION, WARFARIN, MAGMITT, POSTERISAN. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4747072-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2005. Male patient, 76 years of age, was diagnosed with prostate cancer
, insomnia, deep vein thrombosis , constipation and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bedridden, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, central venous pressure decreased, dehydration, feeding disorder. Leuprolide dosage: 3.75 MG (3.75 MG,1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with HALCION, WARFARIN, MAGMITT, POSTERISAN. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4772444-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 02, 2005. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bedridden, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, central venous pressure decreased, dehydration. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with HALCION, WARFARIN, MAGMITT, POSTERISAN. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5422973-0
Leuprolide side effect was reported by a Consumer or non-health professional from GERMANY on Aug 15, 2007. Male patient, 69 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: ascites, blood bilirubin increased, fatigue, gamma-glutamyltransferase increased, hepatomegaly, liver function test abnormal, oedema, rash . Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M); FOR YEARS. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4644741-X
Leuprolide side effect was reported by a Consumer or non-health professional from on Apr 20, 2005. Male patient was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, jaundice , lymphocyte stimulation test positive. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with LEUPROLIDE ACETATE, WARFARIN, DIGOXIN, FLIVAS, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4545344-8
Leuprolide side effect was reported by a Consumer or non-health professional from on Dec 29, 2004. Male patient was treated with Leuprolide. After drug was administered, patient experienced the following side effects: ascites, blood bilirubin increased, hepatic failure. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with LANSOPRAZOLE. Patient recovered.